Rare endocrine tumour guidelines
Our rare endocrine tumour guidelines are intended to be a reference document for clinicians presented with the challenge of managing children and young people with rare endocrine tumour diagnoses.
Our rare endocrine tumour guidelines are intended to be a reference document for clinicians presented with the challenge of managing children and young people with rare endocrine tumour diagnoses.
Join us in celebrating excellence at the 2025 CCLG & TYAC Annual Conference. Nominations are now OPEN for the CCLG & TYAC Member Awards!
Sign up to the CCLG Abseil Adventure.
Rhabdomyosarcoma, a cancer that usually affects muscles, is the most common soft-tissue sarcoma in children. Overall, around 65% of children with rhabdomyosarcoma will survive, but the cure rates vary depending on different characteristics of the disease.